CORY MCMAHON: Open Payments
NPI 1679176002 · FORDYCE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 8 payments from 6 companies in 2025. Trend: 2023 $51 · 2024 $120 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: CAPLYTA, AIRSUPRA, Qelbree, INGREZZA, VRAYLAR, ELIQUIS.
Industry payments across AR — which companies pay providers there.
